Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss
Tuesday, July 14, 2026 1 min read
Key Takeaway: Insulet Corporation has partnered with Calm to provide emotional well-being resources for individuals living with diabetes. This collaboration marks Calm's first integrated content partnership with a MedTech company, aiming to support patients, caregivers, and healthcare professionals. The initiative includes mindfulness tools and a new sleep story narrated by Lila Moss.
Price reaction · baseline $162.06 (2026-07-13 close) · hit pre-market · clean, no other PODD news in the window
day 0 close
-1.8%
Market Sentiment Analysis
POSITIVE FACTORS
Partnership aims to enhance emotional well-being for diabetes community.
Introduces mindfulness tools and resources for patients and caregivers.
First integrated content partnership for Calm with a MedTech company.
Full Press Release Details
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced a global partnership with Calm, a leading consumer mental health company, to provide emotional well-being resources for people living with diabetes, their caregivers, and healthcare professionals. The partnership launches Calm’s first-ever integrated content partnership and collection with a MedTech
Frequently Asked Questions
What is the purpose of Insulet's partnership with Calm?
The partnership aims to provide emotional well-being resources for people living with diabetes.
What new content is being introduced through this partnership?
The partnership includes mindfulness tools and a new sleep story narrated by Lila Moss.
Is this Calm's first partnership with a MedTech company?
Yes, this is Calm's first-ever integrated content partnership with a MedTech company.
Who will benefit from the resources provided by this partnership?
The resources are designed for individuals with diabetes, their caregivers, and healthcare professionals.